Cargando…
Vascular Targeting: Recent Advances and Therapeutic Perspectives
The ability to deliver therapeutics site—specifically in vivo—remains a major challenge for the treatment of malignant, inflammatory, cardiovascular, and degenerative diseases. The need to target agents safely, efficiently, and selectively has become increasingly evident because of progress in vascu...
Autores principales: | Hajitou, Amin, Pasqualini, Renata, Arap, Wadih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172921/ https://www.ncbi.nlm.nih.gov/pubmed/16546688 http://dx.doi.org/10.1016/j.tcm.2006.01.003 |
Ejemplares similares
-
Brain endothelial cell‐targeted gene therapy of neurovascular disorders
por: Marchiò, Serena, et al.
Publicado: (2016) -
Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature
por: Paoloni, Melissa C., et al.
Publicado: (2009) -
Aminopeptidase N inhibitors and SARS
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2003) -
Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells
por: Ferrer, Alejandra, et al.
Publicado: (2022) -
Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy
por: Dondossola, Eleonora, et al.
Publicado: (2014)